OncoSystem Directory
Explore organizations in the global Oncology ecosystem
724 organization(s) found
AABB (Association for the Advancement of Blood & Biotherapies)
AABB is an international, not-for-profit Association representing individuals and institutions involved in the fields of transfusion medicine and biotherapies. The Association is committed to improving health through the development and delivery of standards, accreditation and educational programs that focus on optimizing patient and donor care and safety. AABB membership includes physicians, nurses, scientists, researchers, administrators, medical technologists and other health care providers. AABB members are located in more than 80 countries and AABB accredits institutions in more than 50 countries.
Education, Training & Events in Transfusion Medicine and Biotherapies
Bethesda, MD, United States
WebsiteAACR
The American Association for Cancer Research (AACR) is the first and largest cancer research organization dedicated to accelerating the conquest of cancer.
Cancer Research Philadelphia, PA, United States WebsiteAAI (American Association of Immunologists)
AAI is the largest and most prestigious professional association of immunologists in the world with more than 7,700 members from 71 different countries. AAI is dedicated to advancing the knowledge of immunology and its related disciplines, fostering the interchange of ideas and information among investigators, and addressing the potential integration of immunologic principles into clinical practice.
WebsiteAAOC (Asociación Argentina de Oncología Clínica)
In Spanish: "Somos una sociedad multidisciplinar de referencia permanente en nuestro país a la hora de evaluar, participar y generar acciones de intervención en todas las dimensiones de una enfermedad personal y social como el cáncer. Teniendo en cuenta que un paciente oncológico tiene una realidad vital atravesada por múltiples factores que rompen su sentimiento de salud, nuestras acciones están orientadas a mejorar la prevención, detección temprana, tratamientos basados en evidencia, estandarizar la calidad de la atención en todo el país, la accesibilidad y la investigación. De esta forma, contamos con un Congreso Nacional de Prevención anual cuyo objetivo es poner un nuevo enfoque en las líneas educativas para jóvenes profesionales. En materia de prevención interactuamos con Defensoría Nacional y Periodismo. Contamos con la Guía de Tratamiento del Cáncer para oncólogos y un Programa de Consenso para estandarizar el diagnóstico de pacientes con otras sociedades involucradas en su atención. También realizamos un Curso Educativo para todos los becarios de oncología argentinos y un programa de recertificación, asociado al programa de educación continua. Organizamos un Congreso Nacional para evaluar la calidad y relevancia de la evidencia clínica a realizarse en noviembre de este año, y un Congreso Nacional Educativo, a realizarse en octubre de 2021 en Buenos Aires. También estamos involucrados en un Curso Nacional de Oncología Molecular e Inmuno Oncología con un Consejo Nacional Molecular y un Registro Nacional de Ensayos Clínicos denominado MICA, y varias líneas de investigación para jóvenes investigadores. También producimos nuestra propia publicación: «ONCOLOGÍA CLÍNICA», que refleja la actividad investigadora en nuestro País, combinada con un Encuentro de Investigación anual."
Buenos Aires, Argentina WebsiteAbbVie
AbbVie discovers and delivers innovative medicines and solutions that enhance people’s lives.
Oncology, Immunology, Neuroscience, Eye Care and other areas North Chicago, IL, United States WebsiteABHH (Brazilian Association of Hematology, Hemotherapy & Cellular Therapy)
The Brazilian Association of Hematology, Hemotherapy and Cell Therapy (ABHH) was born from the merger of the Brazilian Society of Hematology and Hemotherapy (SBHH) and the Brazilian College of Hematology (CBH). Today, the institution has more than 5 thousand members, after being the first combination of associations in the country. ABHH's mission is to represent the community of professionals in the area of hematology, hemotherapy, and cell therapy. In addition, it also aims to promote, guide, and defend policies and measures that determine ethics, recognition, dignity, and appreciation of the specialty; value quality and equity in the treatment of patients and specialty services; guarantee technical and educational programs for younger professionals to guide quality training and encourage adequate entry into the labor market; attract new professionals to the specialty; and stimulate multidisciplinarity in the development of professionals in the area.
WebsiteAbogen Biosciences
Abogen Biosciences is an industry-leading clinical-stage biotech company, dedicated to the development of transformative medicines through RNA innovations. Established in 2019, the company has built full-scale in-house capabilities to support the entire mRNA drug development cycle - from protein engineering, mRNA sequence design and synthesis, lipid nanoparticle (LNP) delivery, formulation, and all the way to commercial-scale manufacturing.
mRNA-based therapeutics for Oncology, Auto-Immunity and Infectious Diseases Wuxi, Jiangsu, China WebsiteAcera Therapeutics
Costim Control Cure
T cell-directed therapies for the treatment of cancer South San Francisco, CA, United States WebsiteACHA (African Cervical Health Alliance)
Empower communities to increase access to prevention and control of cervical cancer in Africa by 2030, as we work to achieve the WHO 90-70-90 Targets. Vision: an Africa free of cervical cancer
Nairobi, Kenya WebsiteACHO (Asociación Colombiana de Hematología y Oncología)
In Spanish: "La Asociación Colombiana de Hematología y Oncología (ACHO) es una entidad sin ánimo de lucro de carácter privado; participativa y con una estructura y funcionamiento democrático, con sujeción a los valores y principios constitucionales, especialmente a la solidaridad, unidad, participación, pluralidad, con la posibilidad de desempeñar labores públicas. Con Personería 2151 del 18 de septiembre de 1.984 del Ministerio de Justicia y del Derecho, inscrita en la Cámara de Comercio de Bogotá el 30 de agosto de 2.002. ACHO está conformado por cinco categorías de miembros, siendo estas: de Número, Asociados, Adherentes, Honorarios y Eméritos."
Bogotá, Colombia WebsiteACREOL Global (African Center for Research on End of Life Care)
ACREOL Global (African Center for Research on End of Life) is a non-governmental organization dedicated to improving health outcomes through evidence-based policy influence, education, and innovation. We focus on public health issues, including palliative care, and strive to make research more accessible and impactful.
Kigali, Rwanda WebsiteACS (American Cancer Society)
The American Cancer Society (ACS) is the leading cancer-fighting organization dedicated to eliminating cancer through research, education, advocacy, and service.
WebsiteAdagene
Adagene is a Nasdaq listed, global, clinical-stage immunotherapy company redefining the discovery and design of antibodies to open new horizons in the treatment of cancer.
WebsiteAdaptimmune
Our goal is to redefine how cancer is treated on a global basis by developing TCR T-cell therapies with the potential to treat a wide range of cancer types and patients
TCR-engineered T-cell therapies for solid tumors Abingdon, United Kingdom WebsiteAdcoris
Adcoris is a clinical stage biopharmaceutical company focusing on developing the next generation antibody drug conjugate (ADC) and antibody conjugate beyond cytotoxic payload (AXC) therapeutics to address the unmet needs in oncology and autoimmune disease. Our state-of-the-art proprietary technology platform is based on internally developed three pillars of ADC technologies: proprietary and highly active payloads (PHAP�); cleavable, flexible and stable linkers (CLEF�), multifunctional site-specific conjugation (MuSC�).
ADCs and other conjugates for Oncology Hangzhou, Zhejiang, China WebsiteADC Therapeutics
ADC Therapeutics is Fostering the Future of Cancer Therapy Through Targeted Antibody Drug Conjugate Treatments.
ADCs for solid tumors and blood cancers Lausanne, Switzerland WebsiteADIRESCA
In French: "L’ADIRESCA est l’Association nationale des dispositifs spécifiques régionaux en cancérologie (DSRC), elle a pour objet : de promouvoir le rôle et la mission des DSRC ; de promouvoir l’information et les échanges entre les DSRC ; de permettre la mutualisation de moyens et d’expériences en respectant l’objet de chaque DSRC d’organiser des évènements communs aux DSRC (congrès, formations, …) ; d’être un des interlocuteurs privilégiés des instances nationales dans tout ce qui a trait aux DSRC et leurs missions ; et de représenter collectivement les adhérents au niveau national tant auprès des pouvoirs publics, des administrations, des collectivités, que de tous organismes ou institutions publics ou privés. A ce jour l’ADIRESCA rassemble la totalité des 16 DSRC du territoire français (12 DSRC métropolitains et 4 ultra-marins)."
Roubaix, France WebsiteAfrica Cancer Foundation
Non-profit engaging in cancer awareness, training & capacity building, screening, community outreach, and collaborative partnerships to fight cancer in Kenya.
Nairobi, Kenya WebsiteAgenus
At Agenus, we're advancing the next frontier of immuno-oncology (IO) treatments designed to deliver deeper, more durable responses and to help patients live fuller lives beyond cancer treatment.
mAb immunotherapies for treatment of solid tumors Lexington, MA, United States Website